Debiopharm Group has successfully developed five products.
These products include :
Eloxatin®/Elplat®, a DACH platin for the treatment of colorectal cancer
Decapeptyl®/Trelstar®/Pamorelin® 1-month formulation for the treatment of prostate cancer, endometriosis, precocious puberty, in vitro fertilisation programmes, uterine fibroids
Decapeptyl®/Trelstar®/Pamorelin® 3-month formulation for the same indications
Decapeptyl®/Trelstar® 6-month formulation for the same indications
Moapar®/Salvacyl® for the treatment of severe sexual deviations
Eloxatin® was awarded the prestigious Prix Galien in 2004. Both Eloxatin®/Elplat® and Decapeptyl®/Trelstar® have been among the top ranking products of Debiopharm’s commercial partners.
